Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Matthay

Showing results (111-120 of 316) with videos related to

Pageof 32
Sort By:
Cancer Letters|June 1, 2005
Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004Katherine K Matthay, Franz Blaes, Barbara Hero, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 7, 2001
Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examinationM S Uusitalo, K R Van Quill, I U Scott, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 17, 2012
Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG)A Porzig, K K Matthay, S Dubois, et al.
AJR. American Journal of Roentgenology|October 1, 1996
Renal cell carcinoma after therapy for neuroblastomaL F Donnelly, I O Rencken, K Shardell, et al.
Pediatric Blood & Cancer|April 12, 2012
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastomaAraz Marachelian, Hiroyuki Shimada, Hideki Sano, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Telomerase expression in primary neuroblastomasC P Reynolds, J J Zuo, N W Kim, et al.
Pediatric Blood & Cancer|February 18, 2011
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology GroupArlene Naranjo, Marguerite T Parisi, Barry L Shulkin, et al.
Pediatric Blood & Cancer|March 2, 2013
Infections in hospitalized children and young adults with acute leukemia in MoroccoJacqueline Depasse, Miguela A Caniza, Asmaa Quessar, et al.
The Journal of Pediatrics|October 13, 2001
Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodiesK Hayward, R J Jeremy, S Jenkins, et al.
Annals of Surgical Oncology|November 1, 1995
Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experienceG M Haase, M C O'Leary, D O Stram, et al.
Pageof 32

Showing results (111-120 of 316) with videos related to

Sort By:
Pageof 32
Cancer Letters|June 1, 2005
Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004Katherine K Matthay, Franz Blaes, Barbara Hero, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 7, 2001
Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examinationM S Uusitalo, K R Van Quill, I U Scott, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 17, 2012
Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG)A Porzig, K K Matthay, S Dubois, et al.
AJR. American Journal of Roentgenology|October 1, 1996
Renal cell carcinoma after therapy for neuroblastomaL F Donnelly, I O Rencken, K Shardell, et al.
Pediatric Blood & Cancer|April 12, 2012
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastomaAraz Marachelian, Hiroyuki Shimada, Hideki Sano, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Telomerase expression in primary neuroblastomasC P Reynolds, J J Zuo, N W Kim, et al.
Pediatric Blood & Cancer|February 18, 2011
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology GroupArlene Naranjo, Marguerite T Parisi, Barry L Shulkin, et al.
Pediatric Blood & Cancer|March 2, 2013
Infections in hospitalized children and young adults with acute leukemia in MoroccoJacqueline Depasse, Miguela A Caniza, Asmaa Quessar, et al.
The Journal of Pediatrics|October 13, 2001
Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodiesK Hayward, R J Jeremy, S Jenkins, et al.
Annals of Surgical Oncology|November 1, 1995
Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experienceG M Haase, M C O'Leary, D O Stram, et al.
Pageof 32